Industrial Enzymes Market: Forecasting Growth Through 2029

1
Industrial Enzymes Market Forecasting Growth
Through 2029
The global industrial enzymes market is projected
to grow from USD 7.9 billion in 2024 to USD 11.2
billion by 2029, registering a CAGR of 7.2
during the forecast period. This growth is
primarily driven by increasing demand across
various manufacturing sectors, including food and
beverages, biofuels, and textiles. Enzymes are
emerging as sustainable alternatives to
conventional chemical processes due to their
eco-friendly nature and efficiency.
Advancements in biotechnology and protein
engineering have significantly expanded
enzyme applications and improved their
effectiveness. Additionally, supportive
government regulations and stringent
environmental lawssuch as the U.S. Toxic
Substances Control Act and the Canadian
Environmental Protection Actare promoting the
adoption of enzyme-based technologies. The rising
global demand for clean-label and organic food
products further accelerates the market, as
enzymes
align with natural and sustainable ingredient
requirements.
2
Download PDF Brochure https//www.marketsandmarke
ts.com/pdfdownloadNew.asp?id237327836 Dominant
Applications Food Beverages The food and
beverage sector is anticipated to lead the
industrial enzymes market in terms of
application during the forecast period. Consumer
preferences are shifting towards natural,
sustainable, and health-conscious food options.
Enzymes are ideal for this shift, offering both
enhanced processing efficiency and the ability to
retain natural product characteristics. They are
instrumental in developing innovative products
like plant-based, lactose-free, and
gluten-free foodssegments that are
experiencing rapid growth. Enzymes also
contribute to improved texture, flavor, and
shelf life, making them valuable for food
manufacturers. As innovation continues to
reshape the food industry, the demand for
enzymes is expected to increase
significantly. Leading Type Segment
Carbohydrases Among enzyme types, carbohydrases
are projected to hold the largest market share
over the forecast period. This segments
growth is driven by rising demand for
processed foods that require enhancements
in texture, flavor, and shelf life.
Carbohydrases facilitate the breakdown of
complex carbohydrates into simple sugars, making
them crucial in industries like baking, brewing,
and biofuel production. Moreover, the
increasing focus on healthier food
formulations has elevated demand for
carbohydrases, as these enzymes assist in
reducing sugar content. They enable the
production of low- calorie sweeteners by
converting starches into sugars. The surge in
biofuel production, driven by the need for
renewable energy sources, also contributes to
this segments expansion. Carbohydrases play a
key role in converting biomass into fermentable
sugars essential for bioethanol
manufacturing. Request Sample Pages https//www.
marketsandmarkets.com/requestsampleNew.asp?id2373
27836 Regional Insights Asia Pacific Leads in
Growth The Asia Pacific region is expected to
register the highest CAGR in the industrial
enzymes market during the forecast period. The
regions rapidly growing food and beverage
industry is adopting enzymes to improve product
quality and shelf life. Government initiatives
promoting biofuels have also boosted enzyme usage
in bioethanol production. Additionally, the
textile industrys expansion and its shift
towards environmentally friendly processes are
driving enzyme demand. Agricultural
advancements focused on sustainable farming
further support the adoption of enzyme
technologies in the region. Leading Industrial
Enzymes Manufacturers The key players in the
industrial enzymes market include BASF
(Germany), Novozymes (Denmark), DuPont (US),
DSM (Netherlands), Associated British Foods
plc (UK), Kerry Group plc. (Ireland),
Advanced Enzyme Technologies. (India), Chr.
Hansen Holding A/S (Denmark), Amano Enzyme
Inc.
(Japan), Aumgene Biosciences Pvt. Ltd. (India).
3
BASF In April 2021, in order to invest at the
Kundl/Schaftenau Campus in Austria, BASF made an
agreement with Sandoz GmbH, a division of
Novartis. Through this arrangement, BASF is able
to expand the scope of its enzyme and
biotechnology product production. Both sides
agreed that the financial terms of the deal
should remain confidential. The arrangement
enables BASF to increase the size of its
detergent enzyme production facility, extend the
range of its products, and maintain its
market-leading position in the home care and II
sector. One of the worlds top producers of
generic drugs and biosimilars, Sandoz is a branch
of the Novartis Group. The division was created
in 2003 when Novartis combined all of its
generics businesses under the umbrella of
Sandoz, a single well-established global brand.
Since then, Sandoz has expanded into a market
leader in generics, with annual sales of about
USD 10 billion. Novozymes A significant player
in the biotechnology industry, Novozymes offers
biological solutions that use a variety of
enzymes and microbial applications. The business
serves sectors like household care, food and
beverage, bioenergy, agricultural and feed,
and technical and pharmaceutical. The
companys primary business divisions include
household care, food, beverage, and human health.
North America, Latin America, Asia Pacific,
Europe, the Middle East, and Africa are among the
regions that Novozymes has catered to. In North
America and Latin America, the bioenergy market
is largely dominating. The companys technical
pharma division sells enzymes for the
textile, pharmaceutical, and other industries.
In December 2022, Chr. Hansen and Novozymes, two
biotechnology firms, will join to form a new,
enormous global ingredients company. Chr. Hansen
will be purchased by Novozymes for around USD
12.3 billion. The deal is anticipated to be
finalized no later than the fourth quarter of
2023. For more information _at_ https//www.reportsnr
eports.com/food-beverages/industrial-enzymes-
market-forecasting-growth-through-2029/